AIM ImmunoTech (AIM) Misses Q3 EPS by 157c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts AIM Hot Sheet
Price: $0.16 --0%
EPS Growth %: +90.4%
Financial Fact:
Weighted average shares outstanding diluted (in shares): 3.84M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +90.4%
Financial Fact:
Weighted average shares outstanding diluted (in shares): 3.84M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
AIM ImmunoTech (NYSE: AIM) reported Q3 EPS of ($1.57).
For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Goldcana closes $1M private placement of flow-through shares
- AI-powered cyber threats light a fire under cybersecurity stocks
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
